Effects of dietary counseling on vitamin A, B-1, B-2 and zinc status of chronic hemodialysis patients

Twenty-one chronic hemodialysis patients underwent nutritional evaluation and regular dietary counseling to improve the protein and energy intake for 8 weeks. As a result, the mean serum potassium and phosphorus concentrations were increased but were still within the normal ranges. After counseling,...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Medical Association of Thailand Vol. 80; no. 11; p. 724
Main Authors Komindr, S, Puchaiwatananon, O, Thirawitayakom, J, Domrongkitchaiporn, S, Songchitsomboon, S
Format Journal Article
LanguageEnglish
Published Thailand 01.11.1997
Subjects
Adult
Chelating Agents - administration & dosage
Contraindications
Counseling
Dietary Supplements
Female
Humans
Kidney Failure, Chronic - physiopathology
Kidney Failure, Chronic - therapy
Male
Middle Aged
Nutritional Status
Phosphorus - blood
Renal Dialysis - adverse effects
Riboflavin - administration & dosage
Thiamine - administration & dosage
Vitamin A
Zinc - administration & dosage
Zinc - deficiency
Online AccessGet more information

Cover

More Information
Summary:Twenty-one chronic hemodialysis patients underwent nutritional evaluation and regular dietary counseling to improve the protein and energy intake for 8 weeks. As a result, the mean serum potassium and phosphorus concentrations were increased but were still within the normal ranges. After counseling, the frequency of abnormal TPPE and EGRAC were decreased (9.5 to 4.8 per cent and 19 to 14.3 per cent, respectively) while the frequency of hypervitaminosis A was increased from 67 to 81 per cent. Though the evidence of zinc deficiency was decreased from 81 to 62 per cent after counseling, mean serum zinc levels were low in both periods and inadequate vitamin B status cannot be totally eradicated due to the limitation of food selection. Therefore, regular supplementation of vitamin B complex is required, whereas, vitamin A supplementation must be prohibited in chronic HD patients. Small daily doses of potassium chelator and phosphate binder are mandatory if improvement of nutritional status is aimed to be one of the therapeutic goals.
ISSN:0125-2208